HK1053840A1 - 新型化合物 - Google Patents

新型化合物 Download PDF

Info

Publication number: HK1053840A1
Authority: HK; Hong Kong
Prior art keywords: novel compounds; polypeptides; polynucleotides; disclosed; methods
Prior art date: 2000-04-27

Application number

HK03104434.3A

Other languages

English (en)

Inventor

Agarwal Pankaj

R. Murdock Paul

K. Rizvi Safia

F. Smith Randall

Xiang Zhaoying

S. Kabnick Karen

Lai Ying-Ta

Xie Qing

Original Assignee

Smithkline Beecham Corporation

Smithkline Beecham Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-04-27

Filing date

2001-04-26

Publication date

2003-11-07

2001-04-26 Application filed by Smithkline Beecham Corporation, Smithkline Beecham Plc filed Critical Smithkline Beecham Corporation

2003-11-07 Publication of HK1053840A1 publication Critical patent/HK1053840A1/zh

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C07H21/04—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids with deoxyribosyl as saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Genetics & Genomics (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Biomedical Technology (AREA)
Reproductive Health (AREA)
Wood Science & Technology (AREA)
Biotechnology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pain & Pain Management (AREA)
Pulmonology (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Immunology (AREA)
Microbiology (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
General Engineering & Computer Science (AREA)
Dermatology (AREA)
Physical Education & Sports Medicine (AREA)
Psychology (AREA)
Toxicology (AREA)

HK03104434.3A 2000-04-27 2001-04-26 新型化合物 HK1053840A1 (zh)

Applications Claiming Priority (9)

Application Number	Priority Date	Filing Date	Title
US19996300P	2000-04-27	2000-04-27
US60/199,963		2000-04-27
US20333600P	2000-05-11	2000-05-11
US60/203,336		2000-05-11
US20708700P	2000-05-25	2000-05-25
US60/207,087		2000-05-25
US20754600P	2000-05-26	2000-05-26
US60/207,546		2000-05-26
PCT/US2001/013360 WO2001081363A1 (en)	2000-04-27	2001-04-26	Novel compounds

Publications (1)

Publication Number	Publication Date
HK1053840A1 true HK1053840A1 (zh)	2003-11-07

Family

ID=27498358

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK03104434.3A HK1053840A1 (zh)	2000-04-27	2001-04-26	新型化合物

Country Status (15)

Country	Link
EP (1)	EP1276755A4 (zh)
JP (1)	JP2003530869A (zh)
KR (1)	KR20030032940A (zh)
CN (1)	CN1439017A (zh)
AU (1)	AU2001257265A1 (zh)
BR (1)	BR0110402A (zh)
CA (1)	CA2407449A1 (zh)
CZ (1)	CZ20023548A3 (zh)
HK (1)	HK1053840A1 (zh)
HU (1)	HUP0300595A3 (zh)
IL (1)	IL152416A0 (zh)
MX (1)	MXPA02010692A (zh)
NO (1)	NO20025151L (zh)
PL (1)	PL358580A1 (zh)
WO (1)	WO2001081363A1 (zh)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7034132B2 (en)	2001-06-04	2006-04-25	Anderson David W	Therapeutic polypeptides, nucleic acids encoding same, and methods of use
US6558936B1 (en) *	1999-10-01	2003-05-06	Millennium Pharmaceuticals, Inc.	Human lipase proteins, nucleic acids encoding them, and uses of both of these
US6630335B1 (en)	2000-02-11	2003-10-07	Millennium Pharmaceuticals, Inc.	14171 protein kinase, a novel human protein kinase and uses thereof
NZ523122A (en) *	2000-06-22	2004-06-25	Smithkline Beecham Corp	Polypeptides and polynucleotides and methods of identifying agonists and antagonists in relation to treatment of diseases
AU2001271623A1 (en) *	2000-06-30	2002-01-14	Incyte Genomics, Inc.	Human extracellular matrix (ecm)-related tumor marker
US6924364B2 (en)	2000-08-04	2005-08-02	Zymogenetics, Inc.	Human secreted protein, Zzp1
EP1311675B1 (en) *	2000-08-22	2007-02-07	Agensys, Inc.	Nucleic acid and corresponding protein named 158p1d7 useful in the treatment and detection of bladder and other cancers
US7358353B2 (en)	2000-08-22	2008-04-15	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US6875570B2 (en)	2000-09-27	2005-04-05	Curagen Corporation	Proteins and nucleic acids encoding same
WO2002026826A2 (en) *	2000-09-27	2002-04-04	Curagen Corporation	Proteins and nucleic acids encoding same
CA2430257A1 (en) *	2000-11-28	2002-06-06	Amgen, Inc.	Transforming growth factor-beta-related molecules and uses thereof
CA2439637A1 (en)	2001-03-08	2002-09-19	Immunex Corporation	Human serpin polypeptides
US6921807B2 (en)	2001-03-29	2005-07-26	Zymogenetics, Inc.	Proteinase inhibitor ZSERP9
US7033790B2 (en)	2001-04-03	2006-04-25	Curagen Corporation	Proteins and nucleic acids encoding same
US20020172995A1 (en) *	2001-05-17	2002-11-21	Wei Shao	Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
US20040259779A1 (en) *	2001-07-06	2004-12-23	Teit Johansen	Novel neurotrophic factors
US20030215852A1 (en) *	2002-04-01	2003-11-20	Wyeth	Novel pancortin-Pablo protein interactions and methods of use thereof
AU2004210975B2 (en) *	2003-02-10	2008-04-10	Agensys, Inc.	Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers
US7422906B2 (en)	2003-02-10	2008-09-09	Taisho Pharmaceutical Co., Ltd.	Apoptosis-inducing gene and utilization of the same
CA2534353A1 (en) *	2003-08-01	2005-02-10	Zymogenetics, Inc.	Adipocyte complement related protein zacrp11
US7399469B2 (en)	2004-03-26	2008-07-15	Pdl Biopharma, Inc.	Anti-LFL2 antibodies for the diagnosis, prognosis and treatment of cancer
PL2887959T3 (pl)	2012-08-23	2019-04-30	Agensys Inc	Koniugaty leków i przeciwciał (adc), które wiążą białka 158p1d7
US10828318B2 (en) *	2016-01-06	2020-11-10	Yeda Research And Development Co. Ltd.	Compositions and methods for treating malignant, autoimmune and inflammatory diseases
CN108178797B (zh) *	2017-12-29	2020-12-01	西南大学	一种抗家蚕BmSRC多克隆抗血清、制备方法及应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU6782894A (en) *	1994-05-05	1995-11-29	Human Genome Sciences, Inc.	Human dnase
US5830744A (en) *	1995-06-06	1998-11-03	Human Genome Sciences, Inc.	Gene encoding human Dnase
AU3395900A (en) *	1999-03-12	2000-10-04	Human Genome Sciences, Inc.	Human lung cancer associated gene sequences and polypeptides

2001
- 2001-04-26 EP EP01930760A patent/EP1276755A4/en not_active Withdrawn
- 2001-04-26 PL PL01358580A patent/PL358580A1/xx unknown
- 2001-04-26 IL IL15241601A patent/IL152416A0/xx unknown
- 2001-04-26 WO PCT/US2001/013360 patent/WO2001081363A1/en not_active Ceased
- 2001-04-26 CA CA002407449A patent/CA2407449A1/en not_active Abandoned
- 2001-04-26 HK HK03104434.3A patent/HK1053840A1/zh unknown
- 2001-04-26 BR BR0110402-0A patent/BR0110402A/pt not_active IP Right Cessation
- 2001-04-26 AU AU2001257265A patent/AU2001257265A1/en not_active Abandoned
- 2001-04-26 HU HU0300595A patent/HUP0300595A3/hu unknown
- 2001-04-26 JP JP2001578451A patent/JP2003530869A/ja not_active Withdrawn
- 2001-04-26 MX MXPA02010692A patent/MXPA02010692A/es unknown
- 2001-04-26 CN CN01811752A patent/CN1439017A/zh active Pending
- 2001-04-26 KR KR1020027014463A patent/KR20030032940A/ko not_active Withdrawn
- 2001-04-26 CZ CZ20023548A patent/CZ20023548A3/cs unknown
2002
- 2002-10-25 NO NO20025151A patent/NO20025151L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
HUP0300595A2 (hu)	2003-06-28
IL152416A0 (en)	2003-05-29
PL358580A1 (en)	2004-08-09
EP1276755A1 (en)	2003-01-22
MXPA02010692A (es)	2003-03-10
CZ20023548A3 (cs)	2003-05-14
KR20030032940A (ko)	2003-04-26
NO20025151L (no)	2002-12-13
NO20025151D0 (no)	2002-10-25
BR0110402A (pt)	2003-02-11
HUP0300595A3 (en)	2007-06-28
CA2407449A1 (en)	2001-11-01
JP2003530869A (ja)	2003-10-21
CN1439017A (zh)	2003-08-27
AU2001257265A1 (en)	2001-11-07
EP1276755A4 (en)	2004-03-31
WO2001081363A1 (en)	2001-11-01

Publication	Publication Date	Title
HK1053840A1 (zh)	2003-11-07	新型化合物
WO2001066690A3 (en)	2004-05-21	Novel compounds
MXPA03000227A (es)	2004-05-21	Compuestos novedosos.
WO2001072961A3 (en)	2002-06-20	Novel compounds
EP0939124A3 (en)	2001-03-21	MGBP1 sequences
WO2001004141A3 (en)	2001-05-25	Seripancrin
WO2002004600A3 (en)	2002-06-20	Novel compounds
EP0879888A3 (en)	1999-07-14	Patched-2 polypeptides and polynucleotides and methods for their production
WO2002008253A3 (en)	2002-05-02	A NOVEL MEMBER OF THE EphA RECEPTOR FAMILY
WO2001083744A3 (en)	2002-04-18	Natrium-calcium exchanger protein
EP0943684A3 (en)	2002-01-23	Frizzled-like polypeptides and polynucleotides
WO2001032864A3 (en)	2001-12-06	Gpcr-kd5 polypeptides and dna sequences thereof
EP0887416A3 (en)	1999-03-31	Human AFC1
WO2002014355A3 (en)	2002-09-19	Novel mitogen activated kinase
WO2001083768A3 (en)	2002-04-11	Serine-threonine kinase
EP0890646A3 (en)	2001-07-18	HE2NW40 Serine Protease
EP0937777A3 (en)	1999-11-24	GABA receptors and their uses
EP0887415A3 (en)	1999-01-07	Human RCE1
WO2001068816A8 (en)	2002-02-07	Human histamine h3 gene variant-3
WO2001062779A3 (en)	2002-05-10	New transcription factor carp-2
WO2001085921A3 (en)	2002-04-04	Human serine-threonine kinase-4
WO2001077150A3 (en)	2002-03-28	Serine-threonine kinase
WO2001072963A3 (en)	2002-02-28	Novel human uridine kinase
WO2001029178A3 (en)	2001-09-13	Epo primary response gene 1, eprg1
WO2001079269A3 (en)	2002-03-07	Lipid binding protein 4